Evaxion Biotech announced that it has appointed Glenn S. Vraniak as Chief Financial Officer, effective October 31, 2019. Evaxion further strengthened the senior executive team with the addition of Jürgen Langhärig as Head of Business Development, and Marianne Søgaard as Senior Vice-President, Corporate Affairs and General Counsel. Langhärig joins Evaxion from Serodus.